Trials / Conditions / CMV Disease
CMV Disease
4 registered clinical trials studyying CMV Disease.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Letermovir Versus Valganciclovir to Prevent Human Cytomegalovirus Disease in Kidney Transplant Recipients (MK- NCT03443869 | Merck Sharp & Dohme LLC | Phase 3 |
| Withdrawn | Adoptive Immunotherapy for CMV Disease NCT00159055 | Hadassah Medical Organization | Phase 1 / Phase 2 |
| Completed | Long Term Use of Valganciclovir for Prophylaxis of CMV Disease in Kidney and Pancreas Transplant Patients NCT00225394 | University of Massachusetts, Worcester | — |
| No Longer Available | Expanded Access Protocol of ATA230 (Third-Party Donor-Derived CMV-CTLs) for the Treatment of CMV Viremia or Di NCT03010332 | Atara Biotherapeutics | — |